Literature DB >> 23168390

3D-FSE Isotropic MRI of the Lumbar Spine: Novel Application of an Existing Technology.

Daniel J Blizzard1, Andrew H Haims, Andrew W Lischuk, Rattalerk Arunakul, Joshua W Hustedt, Jonathan N Grauer.   

Abstract

STUDY
DESIGN: Retrospective diagnostic trial.
OBJECTIVE: To determine the diagnostic performance of 3-dimensional isotropic fast/turbo spin-echo (3D-TSE) in routine lumbar spine magnetic resonance imaging (MRI). SUMMARY OF BACKGROUND DATA: Conventional 2-dimensional fast spin-echo (2D-FSE) MRI requires independent acquisition of each desired imaging plane. This is time consuming and potentially problematic in spine imaging, as the plane of interest varies along the vertical axis due to lordosis, kyphosis, or possible deformity. 3D-TSE provides the capability to acquire volumetric data sets that can be dynamically reformatted to create images in any desired plane.
METHODS: Eighty subjects scheduled for routine lumbar MRI were included in a retrospective trial. Each subject underwent both 3D-TSE and conventional 2D-FSE axial and sagittal MRI sequences. For each subject, the 3D-TSE and 2D-FSE sequences were separately evaluated (minimum 4 wk apart) in a randomized order and read independently by 4 reviewers. Images were evaluated using specific criteria for stenosis, herniation, and degenerative changes.
RESULTS: The intermethod reliability for the 4 reviewers was 85.3%. Modified intermethod reliability analysis, disregarding disagreements between the lowest 2 descriptors for appropriate criteria (equivalent to "none" and "mild"), revealed average overall agreement of 94.6%. Using the above, modified criteria, interobserver variability for 3D-TSE was 89.1% and 88.3% for 2D-FSE (P=0.05), and intraobserver variability for 3D-TSE was 87.2% and 82.0% for 2D-FSE (P<0.01). The intermethod agreement between 3D-TSE and 2D-FSE was statistically noninferior to intraobserver 2D-FSE variability (P<0.01).
CONCLUSIONS: This systematic evaluation showed that there is a very high degree of agreement between diagnostic findings assessed on 3D-TSE and conventional 2D-FSE sequences. Overall, intermethod agreement was statistically noninferior to the intraobserver agreement between repeated 2D-FSE evaluations. Overall, this study shows that 3D-TSE performs equivalently, if not superiorly to 2D-FSE sequences. Reviewers found particular utility for the ability to manipulate image planes with the 3D-TSE if there was greater pathology or anatomic variation.

Entities:  

Mesh:

Year:  2015        PMID: 23168390     DOI: 10.1097/BSD.0b013e31827a32ee

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  4 in total

1.  High contrast between lumbar nerve roots and surrounding structures using dual echo 3D turbo spin echo additional fusion images.

Authors:  Naoko Kinoshita; Shigeko Tanaka; Yuko Sugimori; Koichi Nakahira; Koji Ryoke; Toshiyuki Matsuoka; Masayuki Fujioka; Yukio Miki
Journal:  Jpn J Radiol       Date:  2018-06-12       Impact factor: 2.374

2.  Diagnosis of Nerve Root Compromise of the Lumbar Spine: Evaluation of the Performance of Three-dimensional Isotropic T2-weighted Turbo Spin-Echo SPACE Sequence at 3T.

Authors:  Jinkyeong Sung; Won-Hee Jee; Joon-Yong Jung; Jinhee Jang; Jin-Sung Kim; Young-Hoon Kim; Kee-Yong Ha
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

3.  Evaluation of diagnostic value and T2-weighted three-dimensional isotropic turbo spin-echo (3D-SPACE) image quality in comparison with T2-weighted two-dimensional turbo spin-echo (2D-TSE) sequences in lumbar spine MR imaging.

Authors:  Jomleh Hossein; Faeghi Fariborz; Rasteh Mehrnaz; Rafiei Babak
Journal:  Eur J Radiol Open       Date:  2018-12-28

4.  Confidence in Assessment of Lumbar Spondylolysis Using Three-Dimensional Volumetric T2-Weighted MRI Compared With Limited Field of View, Decreased-Dose CT.

Authors:  Joshua Adam Delavan; Nicholas V Stence; David M Mirsky; Jane Gralla; Michael F Fadell
Journal:  Sports Health       Date:  2016-06-09       Impact factor: 3.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.